Should MicroPort CRM prioritize expanding its pacemaker product line or focus on improving existing cardiac resynchronization therapy devices?

Introduction

The trade-off we're examining today is whether MicroPort CRM should prioritize expanding its pacemaker product line or focus on improving existing cardiac resynchronization therapy (CRT) devices. This decision is crucial for the company's future in the cardiac rhythm management market. I'll analyze this trade-off by considering market dynamics, technological advancements, and patient needs.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm thinking our market position might influence this decision. Could you share our current market share in pacemakers versus CRT devices?

Why it matters: Helps determine if we're stronger in one area and should leverage that strength. Expected answer: Higher market share in pacemakers. Impact: If true, might lean towards expanding pacemakers to capitalize on existing strength.

• Business Context: Based on industry trends, I'm assuming CRT devices have higher profit margins. Is this accurate for our product lines?

Why it matters: Affects the financial impact of our decision. Expected answer: Yes, CRT devices have higher margins. Impact: If true, might favor improving CRT devices for better profitability.

• User Impact: I'm thinking about patient outcomes. Do we have data on the comparative effectiveness of our pacemakers versus CRT devices?

Why it matters: Aligns our decision with patient benefits. Expected answer: CRT devices show better outcomes for certain patient groups. Impact: If true, might prioritize CRT improvements to enhance patient care.

• Technical: Considering the pace of innovation, I'm curious about our R&D pipeline. Are there any breakthrough technologies on the horizon for either product line?

Why it matters: Influences where we should focus our innovation efforts. Expected answer: Potential breakthroughs in both areas, but more immediate in pacemakers. Impact: If true, might lean towards pacemaker expansion to capitalize on near-term innovations.

• Resource: I'm thinking about our team structure. How are our engineering resources currently allocated between pacemakers and CRT devices?

Why it matters: Affects our ability to execute on either option. Expected answer: More resources currently dedicated to pacemakers. Impact: If true, might favor pacemaker expansion due to existing expertise and capacity.